These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25936739)

  • 41. Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.
    Farmer AJ; Wade AN; French DP; Simon J; Yudkin P; Gray A; Craven A; Goyder L; Holman RR; Mant D; Kinmonth AL; Neil HA;
    Health Technol Assess; 2009 Feb; 13(15):iii-iv, ix-xi, 1-50. PubMed ID: 19254484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls.
    Nathanson D; Svensson AM; Miftaraj M; Franzén S; Bolinder J; Eeg-Olofsson K
    Diabetologia; 2021 Jul; 64(7):1595-1603. PubMed ID: 33774713
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of structured self-monitoring of blood glucose, with and without additional TeleCare support, on overall glycaemic control in non-insulin treated Type 2 diabetes: the SMBG Study, a 12-month randomized controlled trial.
    Parsons SN; Luzio SD; Harvey JN; Bain SC; Cheung WY; Watkins A; Owens DR
    Diabet Med; 2019 May; 36(5):578-590. PubMed ID: 30653704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The use of flash glucose monitoring significantly improves glycemic control in type 2 diabetes managed with basal bolus insulin therapy compared to self-monitoring of blood glucose: A prospective observational cohort study.
    Bosi E; Gregori G; Cruciani C; Irace C; Pozzilli P; Buzzetti R
    Diabetes Res Clin Pract; 2022 Jan; 183():109172. PubMed ID: 34883185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact and duration effect of telemonitoring on ΗbA1c, BMI and cost in insulin-treated Diabetes Mellitus patients with inadequate glycemic control: A randomized controlled study.
    Fountoulakis S; Papanastasiou L; Gryparis A; Markou A; Piaditis G
    Hormones (Athens); 2015; 14(4):632-43. PubMed ID: 26188234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
    Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
    Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences for Percentage Times in Glycemic Range Between Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring in Adults with Type 1 Diabetes: Analysis of the REPLACE-BG Dataset.
    Avari P; Uduku C; George D; Herrero P; Reddy M; Oliver N
    Diabetes Technol Ther; 2020 Mar; 22(3):222-227. PubMed ID: 31613142
    [No Abstract]   [Full Text] [Related]  

  • 48. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study.
    Šoupal J; Petruželková L; Grunberger G; Hásková A; Flekač M; Matoulek M; Mikeš O; Pelcl T; Škrha J; Horová E; Škrha J; Parkin CG; Svačina Š; Prázný M
    Diabetes Care; 2020 Jan; 43(1):37-43. PubMed ID: 31530663
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized controlled trial of the effect of real-time telemedicine support on glycemic control in young adults with type 1 diabetes (ISRCTN 46889446).
    Farmer AJ; Gibson OJ; Dudley C; Bryden K; Hayton PM; Tarassenko L; Neil A
    Diabetes Care; 2005 Nov; 28(11):2697-702. PubMed ID: 16249542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of supported telemetric monitoring in people with type 2 diabetes: study protocol for a randomised controlled trial.
    Wild S; Hanley J; Lewis S; McKnight J; McCloughan L; Padfield P; Paterson M; Pinnock H; McKinstry B
    Trials; 2013 Jul; 14():198. PubMed ID: 23829417
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Young patients with type 1 diabetes poorly controlled and poorly compliant with self-monitoring of blood glucose: can technology help? Results of the i-NewTrend randomized clinical trial.
    Di Bartolo P; Nicolucci A; Cherubini V; Iafusco D; Scardapane M; Rossi MC
    Acta Diabetol; 2017 Apr; 54(4):393-402. PubMed ID: 28138788
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Telecare Provides comparable efficacy to conventional self-monitored blood glucose in patients with type 2 diabetes titrating one injection of insulin glulisine-the ELEONOR study.
    Del Prato S; Nicolucci A; Lovagnini-Scher AC; Turco S; Leotta S; Vespasiani G;
    Diabetes Technol Ther; 2012 Feb; 14(2):175-82. PubMed ID: 22013886
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study.
    Blackberry ID; Furler JS; Ginnivan LE; Manski-Nankervis JA; Jenkins A; Cohen N; Best JD; Young D; Liew D; Ward G; O'Neal DN
    Diabetes Res Clin Pract; 2014 Nov; 106(2):247-55. PubMed ID: 25271117
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glycemic Outcomes in Adults With Type 2 Diabetes Participating in a Continuous Glucose Monitor-Driven Virtual Diabetes Clinic: Prospective Trial.
    Majithia AR; Kusiak CM; Armento Lee A; Colangelo FR; Romanelli RJ; Robertson S; Miller DP; Erani DM; Layne JE; Dixon RF; Zisser H
    J Med Internet Res; 2020 Aug; 22(8):e21778. PubMed ID: 32856597
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Redesigning ambulatory care management for uncontrolled type 2 diabetes: a prospective cohort study of the impact of a Boot Camp model on outcomes.
    Magee MF; Baker KM; Fernandez SJ; Huang CC; Mete M; Montero AR; Nassar CM; Sack PA; Smith K; Youssef GA; Evans SR
    BMJ Open Diabetes Res Care; 2019; 7(1):e000731. PubMed ID: 31798894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of glucose self-monitoring on non-insulin-treated patients with type II diabetes mellitus. Randomized controlled trial comparing blood and urine testing.
    Allen BT; DeLong ER; Feussner JR
    Diabetes Care; 1990 Oct; 13(10):1044-50. PubMed ID: 2170088
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distinct associations of self-monitoring of blood glucose with glycemic control and hypoglycemia between groups of recently diagnosed and long-term follow-up type 2 diabetes: The Taiwan Diabetes Registry.
    Wang JS; Lo SH; Yeh YP; Hwu CM; Huang CN; Hsieh CH; Sheu WH
    Int J Clin Pract; 2021 Sep; 75(9):e14410. PubMed ID: 34048138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. BetaMe: impact of a comprehensive digital health programme on HbA1c and weight at 12 months for people with diabetes and pre-diabetes: study protocol for a randomised controlled trial.
    Sarfati D; McLeod M; Stanley J; Signal V; Stairmand J; Krebs J; Dowell A; Leung W; Davies C; Grainger R
    Trials; 2018 Mar; 19(1):161. PubMed ID: 29506562
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A pragmatic and scalable strategy using mobile technology to promote sustained lifestyle changes to prevent type 2 diabetes in India and the UK: a randomised controlled trial.
    Nanditha A; Thomson H; Susairaj P; Srivanichakorn W; Oliver N; Godsland IF; Majeed A; Darzi A; Satheesh K; Simon M; Raghavan A; Vinitha R; Snehalatha C; Westgate K; Brage S; Sharp SJ; Wareham NJ; Johnston DG; Ramachandran A
    Diabetologia; 2020 Mar; 63(3):486-496. PubMed ID: 31919539
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Value and utility of self-monitoring of blood glucose in non-insulin-treated patients with type 2 diabetes mellitus.
    Blevins T
    Postgrad Med; 2013 May; 125(3):191-204. PubMed ID: 23748520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.